Auteur J. GREBELY

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

A global meta-analysis of the prevalence of HIV, hepatitis C virus, and hepatitis B virus among people who inject drugs - Do gender-based differences vary by country-level indicators?

J. LEUNG ; A. PEACOCK ; S. COLLEDGE ; J. GREBELY ; E. B. CUNNINGHAM ; M. HICKMAN ; P. VICKERMAN ; J. STONE ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; L. HINES ; P. GRIFFITHS ; R. P. MATTICK ; L. DEGENHARDT ; S. LARNEY | 2019
Dans Journal of Infectious Diseases (Vol.220, n°1, July 2019) Article : Périodique

BACKGROUND: Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses (BBVs), but gender-based differences in BBV prevalence have not been systematically examined. MET[...]

Plus d'info

Ajouter à la sélection

Global patterns of opioid use and dependence: harms to populations, interventions, and future action [Drug use 1]

L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY | 2019
Dans Lancet (The) (Vol.394, n°10208, 26 October 2019) Article : Périodique

We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]

Plus d'info

Ajouter à la sélection

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY | 2017
Dans Lancet Global Health (The) (Vol.5, n°12, December 2017) Article : Périodique

Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]

Plus d'info

Ajouter à la sélection

Lien externe

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

S. LARNEY ; A. PEACOCK ; J. LEUNG ; S. COLLEDGE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY ; K. V. DUMCHEV ; P. GRIFFITHS ; L. HINES ; E. B. CUNNINGHAM ; R. P. MATTICK ; M. LYNSKEY ; J. MARSDEN ; J. STRANG ; L. DEGENHARDT | 2017
Dans Lancet Global Health (The) (Vol.5, n°12, December 2017) Article : Périodique

Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution ther[...]

Plus d'info

Ajouter à la sélection

Lien externe

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT | 2019
Dans Addiction (Vol.114, n°1, January 2019) Article : Périodique

BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]

Plus d'info

Ajouter à la sélection

Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

A. PEACOCK ; J. LEUNG ; S. LARNEY ; S. COLLEDGE ; M. HICKMAN ; J. REHM ; G. A. GIOVINO ; R. WEST ; W. HALL ; P. GRIFFITHS ; R. ALI ; L. GOWING ; J. MARSDEN ; A. J. FERRARI ; J. GREBELY ; M. FARRELL ; L. DEGENHARDT | 2018
Dans Addiction (Vol.113, n°10, October 2018) Article : Périodique

AIMS: This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addresse[...]

Plus d'info

Ajouter à la sélection

Lien externe

Hepatitis C virus reinfection in injection drug users

J. GREBELY ; B. CONWAY ; RAFFA J. D. ; C. LAI ; M. KRAJDEN ; M. W. TYNDALL | 2006
Périodique

ENGLISH : Spontaneous clearance of hepatitis C (HCV) may provide protection against reinfection. In a large community-based cohort study of 3,553 inner-city residents (mainly injection drug users), we identified HCV-infected individuals in who[...]

Plus d'info

Ajouter à la sélection

Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada

E. FORTIER ; S. B. HOJ ; M. P. SYLVESTRE ; A. A. ARTENIE ; N. MINOYAN ; D. JUTRAS-ASWAD ; J. GREBELY ; J. BRUNEAU | 2021
Dans International Journal of Drug Policy (Vol.96, October 2021) Article : Périodique

Background: Frequent injecting increases hepatitis C (HCV) acquisition risk among people who inject drugs (PWID). However, few studies have examined how temporal fluctuations in injecting frequency may affect HCV infection risk. Thus, this study[...]

Plus d'info

Ajouter à la sélection

Lien externe

Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis

L. T. TRAN ; A. PEACOCK ; S. COLLEDGE ; S. MEMEDOVIC ; J. GREBELY ; J. LEUNG ; S. LARNEY ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; M. HICKMAN ; L. DEGENHARDT | 2020
Dans International Journal of Drug Policy (Vol.84, October 2020) Article : Périodique

Background: Injecting risk behaviour, such as receptive sharing of injecting equipment and/or re-using one's equipment, is associated with bloodborne virus transmission and infections in people who inject drugs (PWID). We aimed to estimate preva[...]

Plus d'info

Ajouter à la sélection

Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis

E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY | 2023
Dans International Journal of Drug Policy (Vol.111, January 2023) Article : Périodique

Background: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]

Plus d'info

Ajouter à la sélection

Lien externe

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review

S. BAJIS ; G. J. DORE ; B. HAJARIZADEH ; E. B. CUNNINGHAM ; L. MAHER ; J. GREBELY | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Background: The burden of hepatitis C virus (HCV) infection is escalating among people who inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic review was to evaluate the effectiveness of interventions to[...]

Plus d'info

Ajouter à la sélection

Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis

C. MACDONALD ; G. MACPHERSON ; O. LEPPAN ; L. T. TRAN ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. GREBELY ; M. FARRELL ; F. L. ALTICE ; L. DEGENHARDT | 2024
Dans Lancet Public Health (The) (Vol.9, n°9, September 2024) Article : Périodique

Background: Mortality, suicide, self-harm, and substance use are elevated among people who are incarcerated. There is a wide range of heterogeneous interventions aimed at reducing these harms in this population. Previous reviews have focused on [...]

Plus d'info

Ajouter à la sélection

Lien externe

Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugs

J. GREBELY ; P. BRUGGMANN ; M. BACKMUND ; G. J. DORE | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique

The majority of hepatitis C virus (HCV) occurs among people who inject drugs (PWID), and the burden of HCV-related liver disease is still increasing. HCV treatment is safe and effective among PWID, and international guidelines encourage HCV trea[...]

Plus d'info

Ajouter à la sélection

Lien externe

Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis

P. WEBB ; J. IRELAND ; S. COLLEDGE-FRISBY ; A. PEACOCK ; J. LEUNG ; P. VICKERMAN ; M. FARRELL ; M. HICKMAN ; J. GREBELY ; L. DEGENHARDT | 2024
Dans International Journal of Drug Policy (Vol.128, June 2024) Article : Périodique

Background: A better understanding of global patterns of drug use among people who inject drugs can inform interventions to reduce harms related to different use profiles. This review aimed to comprehensively present the geographical variation i[...]

Plus d'info

Ajouter à la sélection

Lien externe

Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs [Commentary]

E. DAY ; T. BRODER ; J. BRUNEAU ; S. CRUSE ; M. DICKIE ; S. FISH ; C. GRILLON ; N. LUHMANN ; K. MASON ; E. MCLEAN ; S. TROOSKIN ; C. TRELOAR ; J. GREBELY | 2019
Dans International Journal of Drug Policy (Vol.66, April 2019) Article : Périodique

It is estimated that 6.1 million people with recent injecting drug use (PWID) are living with hepatitis C virus (HCV). Although HCV-related morbidity and mortality among PWID continues to increase, the advent of direct acting antiviral (DAA) HCV[...]

Plus d'info

Ajouter à la sélection